primelinkbio.com Listed by lockbit5 Ransomware Group: Ransomware Claim — What’s Alleged & What To Do
privelinkbio.com has been listed by the LockBit5 ransomware group, with internal files reported to have been exfiltrated. The incident was disclosed on 17 June 2026; an undisclosed number of individuals may be affected, and anyone connected to the organisation should verify their exposure and take appropriate protective steps.
What happened
The incident centers on a listing posted by the lockbit5 group claiming access to systems at primelinkbio.com. The only detail provided in the available record is that internal files were allegedly exfiltrated. No timeline for the intrusion, method of initial access, or volume of data has been disclosed. It remains unconfirmed whether encryption occurred or whether any data was subsequently published.
The group behind it: lockbit5
LockBit operates as a ransomware-as-a-service model in which affiliates deploy the malware and share proceeds with the operators. Public reporting has documented the group’s use of double-extortion tactics, in which data is both encrypted and threatened with disclosure. The group has appeared in multiple law-enforcement alerts and has targeted organizations across sectors. Any specific claim made on its leak site about primelinkbio.com remains an unverified assertion by the group.
primelinkbio.com and its sector
PrimeLink BioTherapeutics develops antibody-drug conjugate therapies, a class of targeted cancer treatments that combine antibodies with cytotoxic agents. Biotechnology companies in this field maintain research data, clinical trial records, regulatory submissions, and intellectual property related to drug development. A breach affecting such an organization can expose sensitive scientific and commercial information whose value extends beyond immediate financial loss.
What data was at risk
The only category named in the listing is internal files. No inventory of file types, patient records, or proprietary documents has been released. Organizations of this type routinely hold research protocols, manufacturing data, employee information, and communications with regulators and partners. The precise contents of the exfiltrated material remain unconfirmed.
Why it matters
Exposure of internal biotechnology files can affect ongoing research programs and competitive positioning. Individuals whose information appears in such files may face risks of identity misuse or unwanted disclosure of health-related details. For the company, the incident adds operational disruption and potential regulatory scrutiny common to organizations handling controlled scientific data.
What to do if you're exposed
Review any accounts that may be linked to the organization and enable multi-factor authentication where available. Monitor statements from PrimeLink BioTherapeutics for official guidance. Individuals can check whether their email address appears in known breach datasets through a free exposure scan offered by established breach-notification services.
AICompiled with AI assistance from public sources and published under our editorial standards.
How this breach connects
More recent breaches
columbiaorthogroup.com Listed by lockbit5 Ransomware Groupsierravistahospital.com Listed by lockbit5 Ransomware Groupdentoncalvary.org Listed by lockbit5 Ransomware Groupdecaturdiagnosticlab.net Listed by lockbit5 Ransomware GroupLatest breaches
Read GalaxyWarden’s full analysis of the primelinkbio.com Listed by lockbit5 Ransomware Group →
Publicly posted by lockbit5 — unverified claim, pending independent verification
Breach listings — particularly those originating from ransomware or leak sites — are third-party claims that may be unverified, incomplete, or inaccurate. A listing does not by itself confirm that a breach occurred or that any specific data was exposed. Severity is an automated assessment, not a definitive rating. Verification status is shown where available.
Attributions to threat groups and methods reflect public reporting and, in some cases, unverified claims made by the groups themselves; they may be incomplete or later revised. Recent Breaches and GalaxyWarden are independent and are not affiliated with, and do not endorse, any company or group named on this page. This information is aggregated from public sources for awareness only and is not legal, security, or investment advice.